Pediatric Injectable Diphenhydramine (Avil) Dosing
Critical Safety Warning: Avoid in Young Children
Injectable diphenhydramine should NOT be used routinely in children under 6 years of age due to significant mortality risk, with 33 deaths attributed to diphenhydramine in this age group between 1969-2006. 1
- The FDA and Pediatric Advisory Committees explicitly recommend against using first-generation antihistamines (including diphenhydramine) in children below 6 years of age for routine allergic symptoms. 1
- Between 1969-2006, there were 69 total antihistamine-related deaths in children under 6 years, with diphenhydramine responsible for 33 of these fatalities. 1
FDA-Approved Dosing (When Medically Necessary)
For children (excluding premature infants and neonates), the FDA-approved dose is 5 mg/kg/24 hours or 150 mg/m²/24 hours, divided into four doses, with a maximum daily dosage of 300 mg. 2
Practical Dosing Calculation:
- Per-dose calculation: 1.25 mg/kg per dose (since 5 mg/kg/24 hr ÷ 4 doses = 1.25 mg/kg/dose) 2
- Maximum single dose: 50 mg per dose (300 mg/day ÷ 4 = 75 mg, but clinical guidelines cap single doses at 50 mg) 3
- Administration route: Deep intramuscular or intravenous at a rate not exceeding 25 mg/min 2
- Dosing interval: Every 6 hours (four times daily) 2
Clinical Dosing Guidelines (Emergency Use Only)
When diphenhydramine is used as adjunctive therapy in anaphylaxis (never first-line), the recommended dose is 1-2 mg/kg per dose, with a maximum of 50 mg per dose. 3
Age-Specific Considerations:
- Infants and young children: Use the lower end of the dosing range (1 mg/kg) to minimize toxicity risk 3
- Older children and adolescents: The full 1-2 mg/kg dose can be used, not exceeding 50 mg maximum 3
Dosing Examples by Weight:
| Weight | Lower Dose (1 mg/kg) | Upper Dose (2 mg/kg) | Maximum Allowed |
|---|---|---|---|
| 10 kg | 10 mg | 20 mg | 20 mg |
| 20 kg | 20 mg | 40 mg | 40 mg |
| 30 kg | 30 mg | 60 mg | 50 mg (cap) |
| 40 kg | 40 mg | 80 mg | 50 mg (cap) |
Critical Context: Anaphylaxis Management
Diphenhydramine must NEVER replace epinephrine in anaphylaxis—it is purely adjunctive therapy after epinephrine has been administered. 1, 3
Anaphylaxis Treatment Algorithm:
- First-line: Epinephrine 0.01 mg/kg IM (1:1000 dilution) into anterolateral thigh, maximum 0.3-0.5 mg 4
- Repeat epinephrine every 5-15 minutes if symptoms persist 4
- Adjunctive therapy (only after epinephrine): Diphenhydramine 1-2 mg/kg IV/IM (maximum 50 mg) 3, 4
- Additional adjuncts: H2-antihistamine (ranitidine 1 mg/kg) and corticosteroids (methylprednisolone 1-2 mg/kg) 4
Administration Safety
Intravenous diphenhydramine must be administered slowly (not exceeding 25 mg/min) to prevent seizures and cardiovascular collapse. 2
- Rapid IV administration can precipitate seizures and cardiac arrest, particularly in infants with underlying cardiac conditions 5
- A case report documented cardiac arrest in a 3-month-old infant following a single 1.25 mg/kg IV dose of diphenhydramine 5
- Oral liquid formulations are absorbed more rapidly than tablets and are preferred for acute allergic reactions when the oral route is feasible 3
Monitoring Requirements
Close monitoring for sedation, respiratory suppression, and paradoxical excitation is mandatory, especially when using other sedative agents concurrently. 3
- Paradoxical excitation or agitation may occur in pediatric patients 3
- Monitor for anticholinergic effects including tachycardia, urinary retention, and hyperthermia 3
- Continuous cardiac monitoring is recommended during IV administration 4
Common Pitfalls to Avoid
- Never use diphenhydramine as a sleep aid or to "calm" a child—this is explicitly contraindicated 1
- Never delay epinephrine in anaphylaxis to administer diphenhydramine first 1, 3
- Avoid in children under 6 years for routine allergic symptoms; use second-generation antihistamines (cetirizine, loratadine) instead 1
- Do not exceed 50 mg per single dose regardless of weight-based calculation 3, 2
- Reduce dose by 50% in patients with renal impairment 3
Preferred Alternatives for Routine Allergic Symptoms
Second-generation antihistamines (cetirizine, loratadine) are first-line for pediatric allergic symptoms due to superior safety profiles. 1